From Medscape Pulmonary Medicine

Coverage from the

European Respiratory Society (ERS) International Congress 2018

September 15 - 19, 2018; Paris, France

September 15 - 19, 2018 Paris, France

ERS 2018 First-in-Class COPD Drug Eases Symptoms An inhaled PDE3/4 inhibitor could serve as an add-on to standard treatments for patients with stubborn symptoms and exacerbations of chronic obstructive pulmonary disease, investigators report.
Medscape Medical News, September 17, 2018

Conference News

ERS 2018 Decades After Exposure, Air Pollution Linked to Sick Leave
Medscape Medical News, September 21, 2018
ERS 2018 For Stubborn COPD, Airway Ablation Bolsters Drug Effects
Medscape Medical News, September 20, 2018
ERS 2018 Long-term Benralizumab Safe and Effective for Severe Asthma
Medscape Medical News, September 19, 2018

ERS 2018 First-in-Class COPD Drug Eases Symptoms
Medscape Medical News, September 17, 2018
ERS 2018 Health Effects of Pollution in the Air at ERS 2018
Medscape Medical News, September 10, 2018

Popular News from ERS 2017

Tezepelumab Promising in Adults With Poorly Controlled Asthma Tezepelumab significantly reduced exacerbation rates relative to placebo in adults with poorly controlled asthma despite combined use of bronchodilators and inhaled glucocorticoids, a study found.
Medscape Medical News, Sep 08, 2017
Children With Asthma Prescribed Antibiotics Unnecessarily The rate of antibiotic prescription is at least 60% higher in children with asthma than in those without, new research shows, even though such prescribing is inappropriate.
Medscape Medical News, Sep 11, 2017
Exposure to Disinfectants Linked to COPD There is an association between the regular use of cleaning products and the development of COPD, an analysis of data from the Nurses' Health Study II shows.
Medscape Medical News, Sep 12, 2017

Medscape Pulmonary Medicine© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resources